• Scientific Prog. 2025
• Social Prog. 2025
• Organizing Committee
• Registration
• Accomodation
• About us
• Sponsorship

Scientific Programme 2025

Wednesday 22nd January 2025
SESSION: BEHIND THE CLINICAL TRANSPLANT SCENE - FRAMEWORK AND POLICIES
Moderator: Michiel Erasmus and Young Investigator
	(20 min talk and 10 min Q&A)
16.00–16.30	Eliminating inequities in access to advanced heart failure therapies - past, present and future,	Anna Meyer Heidelberg University Hospital, Heidelberg, Germany
16.30–17.00	Cost effectiveness of VAD in Europe - invisible barriers?	Filip Zemrak Barts, London, UK
17.00–17.30	Review of the anatomy of the lawsuit that changed the allocation policy in 2017	Josh Sonett Colombia University, New York, USA
17.30–18.00	Coffee Break
SESSION: FASCINATING FAILURES AND SURPRISING SUCCESSES
Moderator: Margaret Hannan and Young Investigator
	(10 min talk and 5 min Q&A)
	18.00–18.15 Hyperammonemia following lung transplantation in a patient with primary ciliary dyskinesia	Adbul-Rahman Elhassan National University - Sudan, Khartoum, Sudan
	18.15–18.30 A beautiful beast in lung transplantation	Anja Roden Mayo clinic, Rochester, USA
	18.30–18.45 EXCOR Berlin Heart as bridge to recovery in adult with immediate graft failure post-transplant	Kevin Brennan Freeman Hospital, Newcastle upon Tyne, UK
	18.45–19.00 an 'out of the box' lung transplant on a patient with a giant pulmonalis	Theo Klinkenberg, University Medical Center Groningen, Groningen, the Netherlands
	19.00–19.15 Successful long term PAH targeted treatment effect or failure in optimal timing for lung-transplantation in a young severe APAH-ACHD patient - following WSPH	Göran Rådegran Skane University Hospital, Lund, Sweden
	19.15–19.30 Heart transplantation in situs inversus with dextrocardia	Ronny Gustafsson Lund University Hospital, Lund, Sweden
Thursday 23rd January 2025
SESSION: NOVEL TECHNIQUES IN THE TRANSPLANT JOURNEY
Moderator: Louise Kenny and Young Investigator
	(15 min talk and 5 min Q&A)
16.00–16.20	Future developments in left ventricular assist devices	Martin Strueber, Baptist Medical Group, Memphis, Tennessee
16.20–16.40	Novel biomarkers to evaluate organ preservation and rejection	Jesper Magnusson, Sahlgrenska University Hospital, Gothenburg, Sweden
16.40–17.00	Partial Heart Transplantation – new option, new needs?	Joseph Turek, Duke University Medical Center, Durham, North Carolina, USA
17.00–17.30	Business Meeting
17.30–18.00	Coffee break
SESSION: PULMONARY HYPERTENSION AND THE RIGHT HEART
Moderator: Erik Verschuuren and Young Investigator
	(15 min talk and 5 min Q&A)
18.00–18.20	PAH & Transplant selection - Getting it right or is it ever possible?	Arun Nair, Freeman Hospital, Newcastle upon Tyne, UK
18.20–18.40	A single cannula RAVA-ECMO - a novel solution for PH patients as bridge to lung transplant	Yaron Barac, Rabin Medical Center, Petach-Tikva, Israel
18.40–19.00	Primary isolated right heart failure post-heart transplantation – how to improve outcomes?	Sven-Erik Bartfay, Sahlgrenska University Hospital, Gothenburg, Sweden
19.00–19.30	Session: WERNER ZUBER MEMORIAL LECTURE
Introduction: Paul Corris
	19.00–19.30 How low- and highlanders cope with high altitude: varying hemoglobin levels worldwide	Max Gassmann University of Zurich, Zurich, Switzerland
Friday 24th January 2025
SESSION: ORGAN RECOVERY AND PERFUSION
Moderator: Lars Nolke and Young Investigator
	(20 min talk and 10 min Q&A)
16.00–16.30	Removing the resource burden form the lung transplant centres – centralizing EVLP in Europe	Hasse Møller-Sørensen, Rigshospitalet, Copenhagen, Denmark
16.30–17.00	Hypothermic Oxygenated PErfusion of the heart: HOPE for children	Louise Kenny, Freeman Hospital, Newcastle upon Tyne, UK
17.00–17.30	DCD lung transplantation in children	Glen Westall, Alfred Hospital, Melbourne, Australia
SESSION – OPEN DEBATE
Moderator: Clive Lewis
17.30–18.00	Heart and/or lung transplant should be offered to… Selim Arcasoy Colombia University, New York, USA Ivan Knezevic, University Medical Centre, Ljubljana, Slovenia
18.00–18.20	Coffee break
18.30–19.30	Session: Young Investigators Award (8 min. talk and 2 min Q&A)
Moderator: Michael Perch
	18.20–18.30 Prolonged ex situ oxygenated hypothermic machine preservation in donation after circulatory death donor hearts	Imran Ertegrul, Groningen, The Netherlands
	18.30–18.40Strategies for incorporating recipients’ clinical urgency into donor heart allocation policies - an international comparison	William Jenner, Papworth, UK
	18.40–18.50 Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE)	Shuqi Yang, Groningen, The Netherlands
	18.50–19.00 Ketone body 3-hydroxybutyrate improves myocardial mitochondrial respiratory function during Heart Transplantation	Klaes Van Lenbroch, Aarhus, Denmark
	19.00–19.10 The Impact of Time to Death on Donation after Circulatory Death Lung Transplant Outcomes	Nicholas Chilvers, Newcastle, UK
	19.10–19.20 Biomarkers of Standard Criteria and Marginal Donor Lungs During Ex Vivo Lung Perfusion: A Comparative Study	Michiel Hu, Groningen, The Netherlands
	19.10–19.20 Hypothermic Oxygenated Perfusion and Static Cold Storage Induce Significant Transcriptomic Changes in Porcine Hearts with Minimal Variation between Preservation Methods	Elisa Ballan, Utrecht, The Netherlands